352 related articles for article (PubMed ID: 23102915)
1. The role of non-coding RNAs in diabetic nephropathy: potential applications as biomarkers for disease development and progression.
Alvarez ML; Distefano JK
Diabetes Res Clin Pract; 2013 Jan; 99(1):1-11. PubMed ID: 23102915
[TBL] [Abstract][Full Text] [Related]
2. Where are we in diabetic nephropathy: microRNAs and biomarkers?
McClelland A; Hagiwara S; Kantharidis P
Curr Opin Nephrol Hypertens; 2014 Jan; 23(1):80-6. PubMed ID: 24247820
[TBL] [Abstract][Full Text] [Related]
3. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers for early diagnosis of type 2 diabetic nephropathy: a study based on an integrated biomarker system.
Huang M; Liang Q; Li P; Xia J; Wang Y; Hu P; Jiang Z; He Y; Pang L; Han L; Wang Y; Luo G
Mol Biosyst; 2013 Aug; 9(8):2134-41. PubMed ID: 23719966
[TBL] [Abstract][Full Text] [Related]
5. [Novel biomarkers for diabetic nephropathy].
Araki S
Rinsho Byori; 2014 Feb; 62(2):171-9. PubMed ID: 24800493
[TBL] [Abstract][Full Text] [Related]
6. The pathogenesis of diabetic nephropathy: focus on microRNAs and proteomics.
Conserva F; Pontrelli P; Accetturo M; Gesualdo L
J Nephrol; 2013; 26(5):811-20. PubMed ID: 23543479
[TBL] [Abstract][Full Text] [Related]
7. Markers of and risk factors for the development and progression of diabetic kidney disease.
Macisaac RJ; Ekinci EI; Jerums G
Am J Kidney Dis; 2014 Feb; 63(2 Suppl 2):S39-62. PubMed ID: 24461729
[TBL] [Abstract][Full Text] [Related]
8. Review: The role of microRNAs in kidney disease.
Li JY; Yong TY; Michael MZ; Gleadle JM
Nephrology (Carlton); 2010 Sep; 15(6):599-608. PubMed ID: 20883280
[TBL] [Abstract][Full Text] [Related]
9. Role of the potassium channel KCa3.1 in diabetic nephropathy.
Huang C; Pollock CA; Chen XM
Clin Sci (Lond); 2014 Oct; 127(7):423-33. PubMed ID: 24963668
[TBL] [Abstract][Full Text] [Related]
10. Noncoding RNAs in Diabetic Nephropathy: Pathogenesis, Biomarkers, and Therapy.
Lv J; Wu Y; Mai Y; Bu S
J Diabetes Res; 2020; 2020():3960857. PubMed ID: 32656264
[TBL] [Abstract][Full Text] [Related]
11. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.
Elmarakby AA; Sullivan JC
Cardiovasc Ther; 2012 Feb; 30(1):49-59. PubMed ID: 20718759
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA biomarkers in clinical renal disease: from diabetic nephropathy renal transplantation and beyond.
Nassirpour R; Raj D; Townsend R; Argyropoulos C
Food Chem Toxicol; 2016 Dec; 98(Pt A):73-88. PubMed ID: 26925770
[TBL] [Abstract][Full Text] [Related]
13. microRNA in the development of diabetic complications.
McClelland AD; Kantharidis P
Clin Sci (Lond); 2014 Jan; 126(2):95-110. PubMed ID: 24059587
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of diabetic nephropathy--old buddies and newcomers part 2.
Nawroth PP; Isermann B
Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):667-72. PubMed ID: 20658437
[TBL] [Abstract][Full Text] [Related]
15. Endocannabinoids and the renal proximal tubule: an emerging role in diabetic nephropathy.
Jenkin KA; Verty AN; McAinch AJ; Hryciw DH
Int J Biochem Cell Biol; 2012 Nov; 44(11):2028-31. PubMed ID: 22842535
[TBL] [Abstract][Full Text] [Related]
16. [Diabetic nephropathy. A historical, clinical and diagnostic framework].
Conti AA
Minerva Med; 2002 Oct; 93(5):347-55. PubMed ID: 12410167
[TBL] [Abstract][Full Text] [Related]
17. Circular RNAs; powerful microRNA sponges to overcome diabetic nephropathy.
Mafi A; Yadegar N; Salami M; Salami R; Vakili O; Aghadavod E
Pathol Res Pract; 2021 Nov; 227():153618. PubMed ID: 34649056
[TBL] [Abstract][Full Text] [Related]
18. Emerging roles for miRNAs in the development, diagnosis, and treatment of diabetic nephropathy.
DiStefano JK; Taila M; Alvarez ML
Curr Diab Rep; 2013 Aug; 13(4):582-91. PubMed ID: 23666892
[TBL] [Abstract][Full Text] [Related]
19. Podocyte hypertrophy in diabetic nephropathy.
Kim NH
Nephrology (Carlton); 2005 Oct; 10 Suppl():S14-6. PubMed ID: 16174280
[TBL] [Abstract][Full Text] [Related]
20. New insights into the use of biomarkers of diabetic nephropathy.
Jha JC; Jandeleit-Dahm KA; Cooper ME
Adv Chronic Kidney Dis; 2014 May; 21(3):318-26. PubMed ID: 24780461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
